Aion Therapeutic Inc.
AION
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -219.46% | -9.95% | -2,482.09% | -74.94% | -41.53% |
| Total Depreciation and Amortization | -- | -- | 19,900.00% | 158.14% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 117.21% | 48.45% | 3,423.72% | 150.57% | -25.86% |
| Change in Net Operating Assets | 214.04% | -524.60% | -270.42% | 202.34% | 19.10% |
| Cash from Operations | -236.22% | -125.37% | -632.71% | 302.70% | -638.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -117.25% | -- |
| Total Debt Issued | -- | -- | -100.00% | 90.22% | -- |
| Total Debt Repaid | -- | -- | -20,600.00% | 91.39% | -- |
| Issuance of Common Stock | -37.55% | 29.03% | -- | -- | 287.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.24% | 257.66% | 64,866.67% | 139.45% | 119.71% |
| Foreign Exchange rate Adjustments | 147.68% | -106.26% | 99.38% | -15.57% | 6.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.27% | -63.49% | -103,600.00% | 2,680.00% | -834.62% |
